A medicament having inhibitory activity against NF-κB activation, which comprises a compound represented by the following general formula (I) or a pharmacologically acceptable salt as an active ingredient:
wherein X represents a connecting group, A represents hydrogen atom or acetyl group, E represents an aryl group or a heteroaryl group, and ring X represents an arene or a heteroarene.
Mild fluorofunctionalization of side chains in alkyl substituted aromatics by cesium fluoroxysulfate
作者:Stojan Stavber、Marko Zupan
DOI:10.1021/jo00026a032
日期:1991.12
Fluoration anodique dans le chlorure de methylene (polymethyl- et vinylbenzenes)
作者:A. Bensadat、G. Bodennec、E. Laurent、R. Tardivel
DOI:10.1016/s0022-1139(00)82225-3
日期:1982.5
HOLLOW FIBER, DOPE COMPOSITION FOR FORMING HOLLOW FIBER, AND METHOD OF PREPARING HOLLOW FIBER USING THE SAME
申请人:JUNG Chul-Ho
公开号:US20090282982A1
公开(公告)日:2009-11-19
Disclosed is a hollow fiber that includes a hollow positioned at the center of the hollow fiber, macropores positioned at adjacent to the hollow, and mesopores and picopores positioned at adjacent to macropores, and the picopores are three dimensionally connected to each other to form a three dimensional network structure. The hollow fiber includes a polymer derived from polyamic acid, and the polyamic acid includes a repeating unit obtained from aromatic diamine including at least one ortho-positioned functional group with respect to an amine group and dianhydride.